NEW YORK (GenomeWeb News) – The US Food and Drug Administration yesterday authorized the emergency use of a molecular diagnostic assay to identify cases of swine flu.

The test has not been cleared for marketing by FDA, but the agency granted the US Centers for Disease Control and Prevention the authority to use the multiplex panel to diagnose patients in the US. The rRT-PCR Swine Flu Panel is currently available through a small number of government labs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.